摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(2-methoxyphenyl)butanenitrile | 77853-46-4

中文名称
——
中文别名
——
英文名称
4-(2-methoxyphenyl)butanenitrile
英文别名
——
4-(2-methoxyphenyl)butanenitrile化学式
CAS
77853-46-4
化学式
C11H13NO
mdl
MFCD09744580
分子量
175.23
InChiKey
YQCWMFXWZQZVEC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    145-155 °C(Press: 12-14 Torr)
  • 密度:
    1.014±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    13
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.363
  • 拓扑面积:
    33
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:990266826ffff1de2b9e1a30a38452ba
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-(2-methoxyphenyl)butanenitrile 在 lithium aluminium tetrahydride 作用下, 以 四氢呋喃乙腈 为溶剂, 反应 18.5h, 生成 2-(4-{[4-(2-methoxyphenyl)butyl]amino}butyl)-tetrahydro-1H-pyrrolo[1,2-c]imidazole-1,3(2H)-dione
    参考文献:
    名称:
    New Serotonin 5-HT1A Receptor Agonists Endowed with Antinociceptive Activity in Vivo
    摘要:
    We report the synthesis of new compounds 4-35 based on two different openings (A and B) of the chromane ring present in the previously identified 5-HT1A receptor (5-HT1AR) ligand 3. The synthesized compounds were assessed for binding affinity, selectivity, and functional activity at the 5-HT1AR Selected candidates resulting from B opening were also evaluated for their potential antinociceptive effect in vivo and pharmacokinetic properties in vitro. Analogue 19 [2-(4-{[2-(2-ethoxyphenoxy)ethyl]amino}butyl)tetrahydro-1H-pyrrolo[1,2-c]imidazole-1,3(2H)-dione] has been characterized as a high-affinity and potent 5-HT1AR agonist (K-i = 2.3 nM; EC50 = 19 nM). Pharmacokinetic studies indicated that compound 19 displays a good metabolic stability in human liver microsomes (t(1/2) similar to 3 h and CLint = 3.5 mL/min/kg, at 5 mu M), and a low level of protein binding (25%, at 5 mu M). Interestingly, 19 (3 mg/kg, ip, and 30 mg/kg, po) caused significant attenuation of formalin-induced behavior in early and late phases of the mouse intradermal formalin test of pain, and this in vivo effect was reversed by the selective 5-HT1AR antagonist WAY-100635. Thus, the new 5-HT1AR agonist identified in this work, 19, exhibits oral analgesic activity, and the results herein represent a step toward identifying new therapeutics for the control of pain.
    DOI:
    10.1021/jm400766k
  • 作为产物:
    描述:
    1-(3-氯丙基)-2-甲氧基苯potassium cyanide 、 potassium iodide 作用下, 以 二甲基亚砜 为溶剂, 反应 3.0h, 以70%的产率得到4-(2-methoxyphenyl)butanenitrile
    参考文献:
    名称:
    New Serotonin 5-HT1A Receptor Agonists Endowed with Antinociceptive Activity in Vivo
    摘要:
    We report the synthesis of new compounds 4-35 based on two different openings (A and B) of the chromane ring present in the previously identified 5-HT1A receptor (5-HT1AR) ligand 3. The synthesized compounds were assessed for binding affinity, selectivity, and functional activity at the 5-HT1AR Selected candidates resulting from B opening were also evaluated for their potential antinociceptive effect in vivo and pharmacokinetic properties in vitro. Analogue 19 [2-(4-{[2-(2-ethoxyphenoxy)ethyl]amino}butyl)tetrahydro-1H-pyrrolo[1,2-c]imidazole-1,3(2H)-dione] has been characterized as a high-affinity and potent 5-HT1AR agonist (K-i = 2.3 nM; EC50 = 19 nM). Pharmacokinetic studies indicated that compound 19 displays a good metabolic stability in human liver microsomes (t(1/2) similar to 3 h and CLint = 3.5 mL/min/kg, at 5 mu M), and a low level of protein binding (25%, at 5 mu M). Interestingly, 19 (3 mg/kg, ip, and 30 mg/kg, po) caused significant attenuation of formalin-induced behavior in early and late phases of the mouse intradermal formalin test of pain, and this in vivo effect was reversed by the selective 5-HT1AR antagonist WAY-100635. Thus, the new 5-HT1AR agonist identified in this work, 19, exhibits oral analgesic activity, and the results herein represent a step toward identifying new therapeutics for the control of pain.
    DOI:
    10.1021/jm400766k
点击查看最新优质反应信息

文献信息

  • Low-Valent Titanium-Mediated Radical Conjugate Addition Using Benzyl Alcohols as Benzyl Radical Sources
    作者:Takuya Suga、Shoma Shimazu、Yutaka Ukaji
    DOI:10.1021/acs.orglett.8b02305
    日期:2018.9.7
    A concise method to directly generate benzyl radicals from benzyl alcohol derivatives has been developed. The simple and inexpensive combination of TiCl4(collidine) (collidine = 2,4,6-collidine) and manganese powder afforded a low-valent titanium reagent, which facilitated homolytic cleavage of benzylic C–OH bonds. The application to radical conjugate addition reactions demonstrated the broad scope
    已经开发出一种直接从苄醇衍生物产生苄基的简明方法。TiCl 4(可力丁)(可力丁= 2,4,6-可力丁)和锰粉的简单而廉价的组合提供了一种低价的钛试剂,可促进苄基C-OH键的均质裂解。自由基共轭加成反应的应用证明了该方法的广泛范围。各种苯甲醇衍生物与缺电子烯烃的反应提供了相应的自由基加合物。
  • Nucleophilic Amination of Methoxy Arenes Promoted by a Sodium Hydride/Iodide Composite
    作者:Atsushi Kaga、Hirohito Hayashi、Hiroyuki Hakamata、Miku Oi、Masanobu Uchiyama、Ryo Takita、Shunsuke Chiba
    DOI:10.1002/anie.201705916
    日期:2017.9.18
    Come full circle: A method for the nucleophilic amination of methoxy arenes was established by using sodium hydride (NaH) in the presence of lithium iodide (LiI). This method offers an efficient route to benzannulated nitrogen heterocycles. Mechanistic studies showed that the reaction proceeds through an unusual concerted nucleophilic aromatic substitution.
    围成一圈:在碘化锂(LiI)存在下,使用氢化钠(NaH)建立了甲氧基芳烃的亲核胺化方法。该方法提供了一条有效的途径来制得二环氮杂环。机理研究表明,该反应通过异常的协同的亲核芳族取代进行。
  • Divergent Nickel-Catalysed Ring-Opening–Functionalisation of Cyclobutanone Oximes with Organozincs
    作者:Lucrezia Angelini、Laia Malet Sanz、Daniele Leonori
    DOI:10.1055/s-0039-1690690
    日期:2020.1
    alkylation, arylation, vinylation and alkynylation of nitriles is presented. The methodology uses electron-poor O-Ar cyclic oximes and organozincs as coupling partners. This redox process proceeds through the generation of an iminyl radical and its following ring-opening reaction.
    介绍了用于腈的远程烷基化、芳基化、乙烯基化和炔基化的镍催化策略的开发。该方法使用缺电子的 O-Ar 环状肟和有机锌作为偶联伙伴。该氧化还原过程通过亚胺基自由基的产生及其随后的开环反应进行。
  • Determinants of Early and Late Outcome after Surgery for Type A Aortic Dissection
    作者:Giulio Pompilio、Rita Spirito、Francesco Alamanni、Marco Agrifoglio、Gianluca Polvani、Massimo Porqueddu、Matteo Reali、Paolo Biglioli
    DOI:10.1007/s00268-001-0160-y
    日期:2001.12
    reoperation was 85.4% at 5 years. Multiple factors still influence early and late survival after surgery for type A aortic dissection. Preoperative renal impairment both affects early and late outcome. Early postoperative course affects late outcome in hospital survivors. The presence of the intimal tear in the aortic arch has a negative impact on late survival.
    这项研究的目的是确定在15年内进行A型主动脉夹层手术的患者中与早期和晚期死亡率相关的最重要变量。从1984年1月到1999年3月,有110例患者接受了A型主动脉夹层的手术。88.1%的患者患有急性A型清扫术(AD),11.8%的患者患有慢性清扫术(CD)。心脏压塞和休克分别发生在21.8%和14.5%的患者中。原发性内膜撕裂的位置在升主动脉中占70.9%,在弓中占17.2%,在降主动脉中占7.2%。进行单因素和多因素分析以鉴定与院内死亡独立相关的非栓塞变量。Kaplan-Meier和Cox回归分析以及死亡风险的危害函数用于分析影响整体生存和手术生存的因素。总体住院死亡率为20.9%(23/110例患者),CD占9%,AD占21.6%。紧急手术的住院死亡率为47.6%,而非紧急手术的住院死亡率为13.7%(p <0.01)。单因素分析显示41例术前和手术变量,包括年龄(岁),年龄> 70岁,
  • 7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: Structural investigations at the 5-position to target human A1 and A2A adenosine receptors. Molecular modeling and pharmacological studies
    作者:Lucia Squarcialupi、Vittoria Colotta、Daniela Catarzi、Flavia Varano、Marco Betti、Katia Varani、Fabrizio Vincenzi、Pier Andrea Borea、Nicola Porta、Antonella Ciancetta、Stefano Moro
    DOI:10.1016/j.ejmech.2014.07.060
    日期:2014.9
    In previous research, several 7-amino-2-arylpyrazolo[4,3-d]pyrimidine derivatives were identified as highly potent and selective antagonists at the human A3 adenosine receptor. Structure-activity relationship studies highlighted that affinity and selectivity depended on the nature of the substituents at the 5- and 7-positions of the pyrazolo[4,3-d]pyrimidine scaffold. In particular, small lipophilic residues at the 5-position and a free amino group at position 7 afforded compounds able to bind all four human (h) adenosine receptors. Hence, to shift affinity toward the hA1 and/or hA(2A) subtypes, alkyl and arylalkyl chains of different length were appended at position 5 of the 2-phenylpyrazolo[4,3-d]pyrimidin-7-amine. Among the new compounds, a dual hA1/hA(2A) receptor antagonist was identified, namely the 5-(3-phenylpropyl) derivative 25, which shows high affinity both at human A1 (K(i) = 5.31 nM) and A(2A) (K(i) = 55 nM) receptors. We also obtained some potent and selective antagonists for the A1 receptor, such as the 5-(3-arylpropyl)-substituted compounds 26-31, whose affinities fall in the low nanomolar range (K(i) = 0.15-18 nM). Through an in silico receptor-driven approach, the obtained binding data were rationalized and the molecular bases of the hA1 and hA(2A) AR affinity and selectivity of derivatives 25-31 are explained.
查看更多